Latest blog articles
-
A few weeks ago, I predicted on this blog that 16 July 2020 would be the most important day of the year, for privacy professionals, because of an expected judgment of the Grand Chamber of the Court of Justice of the European Union (CJEU). And I must say: the Court did not disappoint. 16 July has...
-
The ongoing COVID-19 pandemic is arguably one of the biggest crises of modern times. The conflict between the search for a vaccine, and the artificial scarcity created by patent law, has created a catch-22 situation. How will patent law apply to a vaccine under these circumstances?
-
Several pharmaceutical companies all around the world, including in the European Union (EU), have been racing to find a treatment for the virus. Since these may be subject to patent rights, government intervention may be needed.
-
Earlier today, the European Union and the United Kingdom reached agreement on a revised customs plan for Brexit. If approved by the EU Member States, the European Parliament and the UK House of Commons, this deal would allow the United Kingdom to exit the European Union on 31 October 2019 in an...
-
The Swedish Data Protection Authority recently launched an investigation into Umeå University’s handling of sensitive personal data, specifically data obtained from the Danish Police Authority for research purposes.
-
I think that today is a good day to ask the future Members of the European Parliament and American Presidential Candidates to think about a global dimension of data protection and to commit themselves to develop international legislative instruments that have the power to truly enable world-wide...
-
Electronics companies increasingly engage in patent aggregation, that is to accrue patents without using them for manufacturing purposes. So far, it is unclear whether such behaviour has negative effects on innovation. If it did, could EU competition law remedy it?
-
The quality of a granted patent is dependent on the quality of the patent application. For the companies where scientists write their own patents, IP legal training for scientists can help improving their patent drafting skills.
-
Unlike other sectors, improvements in Genetic technology raise issues of morality. The new human gene editing technology CRISPR/CAS9 has raised many such concerns. Can the current patent system deal with these concerns or should morality be dealt with by the inventors themselves?
-
On 6 November 2018 the ICO published it’s report to Parliament (Investigation into the use of data analytics in political campaigns A report to Parliament 6 November 2018).